Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forus Therapeutics
Oakville, Ontario, Canadaforustherapeutics.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Forus Therapeutics Inc. is a Canadian biopharmaceutical company focused on advancing differentiated medicines for hematologic malignancies and other cancers. The company has an exclusive licensing agreement with PharmaEssentia to register and distribute BESREMi® (ropeginterferon alfa‑2b) for polycythemia vera in Canada, with possible expansion to other myeloproliferative neoplasm indications. It also oversees the commercialization of XPOVIO® (selinexor), a first-in-class selective inhibitor of nuclear export approved in Canada for multiple myeloma. BESREMi® has been made available via exceptional importation while Health Canada review proceeds.
- Therapeutic areas
- HematologyOncology
- Modalities
- Protein therapeutics (e.g., ropeginterferon alfa-2b)Small molecules (e.g., selinexor/XPOVIO)
- Industry
- Biotech
02
Partnerships
PharmaEssentia Corporation (exclusive licensing agreement for BESREMi)
Beyond the preview
Go deeper on Forus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Forus Therapeutics.